Excitement is building over remdesivir as a treatment for COVID-19. On Friday, the Food and Drug Administration authorized the emergency use of remdesivir to treat COVID-19, President Trump announced.

The U.S. Food and Drug Administration has approved the use of the antiviral drug remdesivir for children ages 28 days and older. With the decision, the drug becomes the first approved treatment for ...

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved ...

The majority of people who contract COVID-19 don't need to seek treatment and can typically battle the infection on their own, but that's not always the case, and there are various treatments ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Remdesivir treatment is associated with reduced ...

U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir since July as need for the costly antiviral wanes, the Department of Health and Human Services ...

The World Health Organization has updated its ongoing guidance on Covid-19 medications to advise against using the antiviral drug remdesivir to treat hospitalized patients, no matter how severe their ...

A 25% lower all-cause mortality is associated with timely initiation of remdesivir in immunocompromised patients hospitalized for COVID-19. Among patients with immunocompromising conditions who were ...

Please provide your email address to receive an email when new articles are posted on . Remdesivir did not reduce adverse cardiovascular or kidney events in the study cohort. Remdesivir use was ...

Researchers released some good news about a possible treatment for coronavirus Wednesday -- evidence that the experimental drug remdesivir might help patients recover more quickly from the infection.

Appropriate use of remdesivir in patients with COVID-19 who are on hemodialysis may not result in a high risk of side effects, such as hepatotoxicity, according to investigators. Short-term use of ...